ID3 and neoplasm: reveals that inhibitor of differentiation 3 (ID3) empowers Kupffer cells (KCs) to efficiently engulf live tumor cells and activate the lymphoid anti‐tumor immune response, orchestrating a potent anti‐tumor niche and restricting liver tumor growth (Figure 1).1